Hepatocellular Carcinoma Rupture after Introducing Lenvatinib: An Autopsy Case Report

Hepatocellular carcinoma (HCC) hemorrhaging/rupture is a rare adverse effect of lenvatinib, and only limited pathological examinations have been reported. This report presents the case of a 69-year-old man who suffered from cardiac arrest and died 7 days after starting lenvatinib treatment for HCC,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kohya, Risako, Sugiura, Ryo, Yamamoto, Yoshiya, Naruse, Hirohito, Hatanaka, Kazuteru, Kinoshita, Kenji, Abiko, Satoshi, Miyamoto, Shuichi, Suzuki, Kazuharu, Kushibiki, Hanae, Munakata, Satoru, Shimoyama, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125806/
https://www.ncbi.nlm.nih.gov/pubmed/36047124
http://dx.doi.org/10.2169/internalmedicine.0114-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125806/
https://www.ncbi.nlm.nih.gov/pubmed/36047124
http://dx.doi.org/10.2169/internalmedicine.0114-22

Ejemplares similares